RE: “The other co.”10 Jan 2022 21:13
Moniman, I am invested in both Novacyt and Avacata as probably are many others on here.
Nowhere has the drop been bigger than it has here for some. So when talking about losses for many, those really starts here.
This isn’t the BB for talking about the potential upside of Avacta, so I won’t, but it also isn’t the place to be talking it down.
I really hope Pathflow is a success, but did I miss the FDA or EU approval? Have they confirmed how accurate it is for Omicron?
This definitely isn’t the stock we can be on our high horse about.